东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01558 东阳光长江药业

未开盘 05-06 16:08:49

12.660

-0.340

-2.62%

最高13.080	最低12.480	成交量360.08万
今开13.080	昨收13.000	日振幅4.62%
总市值111.40亿	流通市值82.77亿	总股本8.80亿
成交额4,548万	换手率0.55%	流通股本6.54亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01558","market":"HK","secType":"STK","nameCN":"东阳光长江药业","latestPrice":12.66,"timestamp":1714982929014,"preClose":13,"halted":0,"volume":3600800,"delay":0,"floatShares":653767700,"shares":879967700,"eps":2.453977,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.34,"latestTime":"05-06 16:08:49","open":13.08,"high":13.08,"low":12.48,"amount":45479325,"amplitude":0.046154,"askPrice":12.66,"askSize":1400,"bidPrice":12.5,"bidSize":8600,"shortable":3,"etf":0,"ttmEps":2.449178405590907,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715045400000},"adr":0,"listingDate":1451318400000,"adjPreClose":13,"openAndCloseTimeList":[[1714959000000,1714968000000],[1714971600000,1714982400000]],"volumeRatio":1.30275,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01558/","defaultTab":"news","newsList":[{"id":"2433642774","title":"东阳光长江药业(01558)：建议选举第四届董事会董事及监事会监事","url":"https://stock-news.laohu8.com/highlight/detail?id=2433642774","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433642774?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:23","pubTimestamp":1714998237,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东阳光长江药业 发布公告，第三届董事会任期即将届满。监事会已于2024年5月6日召开会议，并考虑及批准唐金龙先生及罗忠华先生为第四届监事会股东代表监事候选人。于2024年4月30日，王胜超先生经公司2024年第一次职工代表大会选举为第四届监事会职工代表监事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117827.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432947895","title":"东阳光长江药业05月03日遭主力抛售903万元 环比增加1405.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432947895","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432947895?lang=zh_cn&edition=full","pubTime":"2024-05-03 16:16","pubTimestamp":1714724203,"startTime":"0","endTime":"0","summary":"05月03日, 东阳光长江药业股价跌0.46%，报收13.00元，成交金额2550万元，换手率0.30%，振幅1.99%，量比0.69。东阳光长江药业今日主力资金净流出903万元，连续3日净流出，上一交易日主力净流出60万元，今日环比增加1405.00%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为44.44%，平均跌幅为1.61%。该股近5个交易日上涨4.00%，主力资金累计净流出985万元；近20日主力资金累计净流入762万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050316171487cdcd4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050316171487cdcd4d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430230444","title":"港股异动 | 东阳光长江药业(01558)现涨超3% 胰岛素接续采购定价较为温和 公司有5个产品拟中标","url":"https://stock-news.laohu8.com/highlight/detail?id=2430230444","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430230444?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:40","pubTimestamp":1714027256,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，东阳光长江药业(01558)现涨超3%，截至发稿，涨3.15%，报12.46港元，成交额1889.5万港元。消息面上，国家医保局近期组织全国各省份开展胰岛素集采协议期满后接续采购，并于4月23日在上海开标。业内普遍认为，此次胰岛素接续采购定价较为温和。拟中选结果显示，东阳光长江药业有5个产品拟中标。国信证券指出，国产胰岛素企业有望通过合理的降价维持主要存量市场，并通过集采争取新产品的放量，考虑到本轮接续采购规则较为温和，预计价格变动因素对短期业绩扰动将小于首次国采，建议积极关注相关公司在此次集采中的中选情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109609.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429891492","title":"东阳光长江药业04月22日遭主力抛售388万元 环比增加3427.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429891492","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429891492?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:16","pubTimestamp":1713773805,"startTime":"0","endTime":"0","summary":"04月22日, 东阳光长江药业股价跌3.24%，报收11.96元，成交金额2584万元，换手率0.33%，振幅4.37%，量比0.73。东阳光长江药业今日主力资金净流出388万元，连续3日净流出，上一交易日主力净流出11万元，今日环比增加3427.27%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为1.61%。该股近5个交易日下跌6.29%，主力资金累计净流出638万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1538万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221617238b45371a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221617238b45371a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428554583","title":"东阳光长江药业盘中异动 大幅下跌5.00%报12.141港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428554583","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428554583?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:45","pubTimestamp":1713404704,"startTime":"0","endTime":"0","summary":"2024年04月18日早盘09时45分，东阳光长江药业股票出现异动，股价急速跳水5.00%。截至发稿，该股报12.141港元/股，成交量30.64万股，换手率0.05%，振幅5.95%。东阳光长江药业股票所在的药品行业中，整体跌幅为0.04%。其相关个股中，君圣泰医药-B、前海健康、海王英特龙涨幅较大，振幅较大的相关个股有君圣泰医药-B、前海健康、东阳光长江药业，振幅分别为23.75%、6.06%、5.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418094504861e6d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418094504861e6d90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428831865","title":"东阳光长江药业(01558)股价下跌5.008%，现价港币$12.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2428831865","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428831865?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:44","pubTimestamp":1713404640,"startTime":"0","endTime":"0","summary":"[下跌股]东阳光长江药业(01558) 股价在上午09:44比前收市价下跌5.008%，现股价为港币$12.14。至目前为止，今日最高价为$12.9，而最低价为$12.14。总成交量为30.64万股，总成交金额为港币$380.13万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240418244/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427844319","title":"广东东阳光药业股份有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2427844319","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427844319?lang=zh_cn&edition=full","pubTime":"2024-04-16 18:24","pubTimestamp":1713263074,"startTime":"0","endTime":"0","summary":"4月16日，据CDE官网消息，广东东阳光药业股份有限公司、东莞市东阳光生物药研发有限公司联合申请药品“德谷胰岛素利拉鲁肽注射液”，获得临床试验默示许可，受理号CXSL2400082。公示信息显示，药品“德谷胰岛素利拉鲁肽注射液”适应症：本品适用于血糖控制不佳的成人 2 型糖尿病患者，在饮食和运动基础上联合其他口服降糖药物，改善血糖控制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161824418783ce2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161824418783ce2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427894099","title":"东阳光长江药业(01558)出现大手卖出51万股，成交价$12.58，涉资641.58万","url":"https://stock-news.laohu8.com/highlight/detail?id=2427894099","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427894099?lang=zh_cn&edition=full","pubTime":"2024-04-16 13:43","pubTimestamp":1713246180,"startTime":"0","endTime":"0","summary":"[大手成交]东阳光长江药业(01558)在下午01:43出现大手卖出，成交量为51万，成交价为港币$12.58，涉资641.58万。至目前为止，股价跌1.101%，今日最高价为$12.68，而最低价为$12.44，总成交量为199.76万股，总成交金额港币$2.511千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404162638/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426277753","title":"东阳光长江药业04月12日遭主力抛售450万元 环比增加533.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426277753","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426277753?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:16","pubTimestamp":1712909768,"startTime":"0","endTime":"0","summary":"04月12日, 东阳光长江药业股价跌1.26%，报收12.52元，成交金额4271万元，换手率0.52%，振幅3.31%，量比1.01。东阳光长江药业今日主力资金净流出450万元，上一交易日主力净流出71万元，今日环比增加533.80%。该股近5个交易日上涨9.68%，主力资金累计净流入1777万元；近20日主力资金累计净流入2655万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121617018b15d0e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121617018b15d0e2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426455670","title":"东阳光药去年营收55亿增13.8%研发投入占比升至11.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426455670","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2426455670?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:47","pubTimestamp":1712735269,"startTime":"0","endTime":"0","summary":"【东阳光(600673)药去年营收增长13.8%，研发投入占比提升至11.2%】 东阳光药近日公布了去年的年度业绩报告。报告显示，公司去年实现营业收入约为55.1亿元，同比增长13.8%。同时，公司去年的研发投入约为6.2亿元，占营业收入的比重提升至11.2%，同比增加1.9个百分点。公司表示，去年营收的增长主要得益于核心产品在糖尿病、心血管疾病等领域的稳定增长。此外，公司在研发方面的持续投入，也为未来产品的创新和市场拓展奠定了基础。公司还计划继续加大研发力度，推动更多创新药品的研发和上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410155613875f43be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410155613875f43be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426104955","title":"东阳光长江药业(01558)上涨5.0%，报12.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426104955","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426104955?lang=zh_cn&edition=full","pubTime":"2024-04-10 10:01","pubTimestamp":1712714513,"startTime":"0","endTime":"0","summary":"4月10日，东阳光长江药业(01558)盘中上涨5.0%，截至10:01，报12.6元/股，成交2619.48万元。宜昌东阳光长江药业股份有限公司是一家专注于抗病毒、内分泌及代谢性疾病、心血管疾病等治疗领域产品的研发、生产及销售的制药企业，拥有覆盖全国的产品分销网络，其核心产品磷酸奥司他韦是中国抗流感病毒市场的主导产品。截至2015年年末，公司在国内生产、推广及销售了33款医药产品，2013至2015年，其磷酸奥司他韦产品在中国区销量名列第一。截至2023年年报，东阳光长江药业营业总收入62.95亿元、净利润19.93亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/10100140176354.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426710181","title":"东阳光长江药业盘中异动 大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426710181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426710181?lang=zh_cn&edition=full","pubTime":"2024-04-10 10:01","pubTimestamp":1712714506,"startTime":"0","endTime":"0","summary":"2024年04月10日早盘10时01分，东阳光长江药业股票出现异动，股价大幅上涨5.16%。东阳光长江药业股票所在的药品行业中，整体跌幅为0.11%。其相关个股中，东阳光长江药业、四环医药、中生联合涨幅较大，振幅较大的相关个股有三爱健康集团、中生联合、联康生物科技集团，振幅分别为17.65%、12.28%、8.60%。消息层面，截至10时01分，《东阳光长江药业：潜在要约人尚未向公司提出明确的可能合并方案》资讯为影响东阳光长江药业的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410100147791f873e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410100147791f873e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425963513","title":"东阳光长江药业(01558)：潜在要约人尚未向公司提出明确的可能合并方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2425963513","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2425963513?lang=zh_cn&edition=full","pubTime":"2024-04-08 17:37","pubTimestamp":1712569041,"startTime":"0","endTime":"0","summary":"东阳光长江药业(01558)发布公告，广东东阳光药业股份有限公司(潜在要约人)宣布...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_26.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_26.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099418.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425536782","title":"东阳光长江药业04月05日主力资金流入423万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2425536782","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425536782?lang=zh_cn&edition=full","pubTime":"2024-04-05 16:16","pubTimestamp":1712304972,"startTime":"0","endTime":"0","summary":"04月05日, 东阳光长江药业股价涨2.34%，报收11.36元，成交金额1797万元，换手率0.24%，振幅4.86%，量比0.90。东阳光长江药业今日主力资金净流入423万元，连续3日净流入，上一交易日主力净流入188万元，今日环比增加125.00%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为46.15%，平均涨幅为4.17%。该股近5个交易日上涨2.71%，主力资金累计净流入532万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入189万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404051616348af386f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404051616348af386f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424171089","title":"东阳光长江药业盘中异动 早盘大幅跳水6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424171089","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424171089?lang=zh_cn&edition=full","pubTime":"2024-04-02 09:30","pubTimestamp":1712021426,"startTime":"0","endTime":"0","summary":"2024年04月02日早盘09时30分，东阳光长江药业股票出现异动，股价急速下挫6.07%。截至发稿，该股报10.221港元/股，成交量5.46万股，换手率0.01%，振幅2.57%。东阳光长江药业股票所在的药品行业中，整体跌幅为0.01%。其相关个股中，赛生药业、联邦制药、石药集团涨幅较大，振幅较大的相关个股有泰凌医药、中生联合、翰森制药，振幅分别为9.09%、6.78%、3.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402093027861e2c0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402093027861e2c0a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424850207","title":"智通港股早知道 | 3月中国制造业采购经理指数重回扩张区间 苏州、厦门和宁波三城同日诞生地王","url":"https://stock-news.laohu8.com/highlight/detail?id=2424850207","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424850207?lang=zh_cn&edition=full","pubTime":"2024-04-01 07:37","pubTimestamp":1711928228,"startTime":"0","endTime":"0","summary":"3月份中国制造业采购经理指数回升明显 重回扩张区间中国物流与采购联合会、国家统计局服务业调查中心今天公布3月份中国采购经理指数。其中，制造业采购经理指数重回扩张区间，经济回升向好势头进一步增强。3月份中国制造业采购经理指数为50.8%，较上月上升1.7个百分点，连续5个月运行在50%以下后，重回扩张区间。归属于公司权益持有人的溢利及全面收益总额为约19.93亿元，同比增加2501.23%。董事会于2024年3月28日审议通过本次增资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1096745.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422240163","title":"《公司业绩》东阳光长江药业(01558.HK)全年纯利19.93亿人币  不派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2422240163","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422240163?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:32","pubTimestamp":1711621920,"startTime":"0","endTime":"0","summary":"东阳光长江药业(01558.HK) 公布截至去年12月底止全年业绩，营业额62.95亿元人民币(下同)，按年升68.1%。纯利19.93亿元，增约25倍；每股盈利2.26元。不派息。(ad/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-28 16:25。)过往派息公布日期派息事项派息内容2023/08/31中期业绩无派息2023/03/24末期业绩无派息 2022/08/26中期业绩无派息 2022/03/21末期业绩无派息 AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190627171508424_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190627171508424_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1338603/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422516830","title":"东阳光长江药业(01558)公布2023年业绩 归母净利约19.93亿元 同比增加2501.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422516830","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422516830?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:18","pubTimestamp":1711621097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东阳光长江药业 公布2023年业绩，营业额为约人民币62.95亿元，同比增加68.08%。归属于公司权益持有人的溢利及全面收益总额为约19.93亿元，同比增加2501.23%。每股基本及摊薄盈利为人民币2.26元。核心产品可威的销售额为55.095亿元，较去年同期增加78.15%。可威销售额的增加主要原因是由于2023年国内人员流动及日常社交活动已日趋正常化，终端医疗机构人流量、诊疗活动及药品处方量恢复势头良好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094903.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422537961","title":"东阳光长江药业03月28日主力资金流出76万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2422537961","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422537961?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:17","pubTimestamp":1711613820,"startTime":"0","endTime":"0","summary":"03月28日, 东阳光长江药业股价涨0.55%，报收10.88元，成交金额883万元，换手率0.12%，振幅1.85%，量比0.64。东阳光长江药业今日主力资金净流出76万元，连续5日净流出，上一交易日主力净流出87万元，今日环比减少12.64%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为33.33%，平均跌幅为1.73%。该股近5个交易日下跌2.68%，主力资金累计净流出494万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1713万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281618128b6cece3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281618128b6cece3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422590899","title":"东阳光长江药业03月27日遭主力抛售87万元 环比增加112.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422590899","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422590899?lang=zh_cn&edition=full","pubTime":"2024-03-27 16:16","pubTimestamp":1711527366,"startTime":"0","endTime":"0","summary":"03月27日, 东阳光长江药业股价跌2.17%，报收10.82元，成交金额1022万元，换手率0.14%，振幅1.99%，量比0.68。东阳光长江药业今日主力资金净流出87万元，连续4日净流出，上一交易日主力净流出41万元，今日环比增加112.20%。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为25.00%，平均跌幅为1.46%。该股近5个交易日下跌1.46%，主力资金累计净流出260万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2316万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271616388b68e408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271616388b68e408&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hec-changjiang.com","stockEarnings":[{"period":"1week","weight":-0.0321},{"period":"1month","weight":0.1144},{"period":"3month","weight":0.4842},{"period":"6month","weight":0.5216},{"period":"1year","weight":0.806},{"period":"ytd","weight":0.334}],"compareEarnings":[{"period":"1week","weight":0.0468},{"period":"1month","weight":0.1109},{"period":"3month","weight":0.1513},{"period":"6month","weight":0.0575},{"period":"1year","weight":-0.0734},{"period":"ytd","weight":0.0898}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。其业务还包括药品的研发、营销及分销。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。其核心产品组合包括“可威”、“尔同舒”、“欧美宁”、“欣海宁”及 “喜宁”。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052152},{"month":2,"riseRate":0.777778,"avgChangeRate":0.088442},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.0661},{"month":4,"riseRate":0.666667,"avgChangeRate":0.018306},{"month":5,"riseRate":0.444444,"avgChangeRate":0.005293},{"month":6,"riseRate":0.75,"avgChangeRate":0.08509},{"month":7,"riseRate":0.5,"avgChangeRate":-0.061204},{"month":8,"riseRate":0.125,"avgChangeRate":-0.056274},{"month":9,"riseRate":0.5,"avgChangeRate":-0.046672},{"month":10,"riseRate":0.5,"avgChangeRate":0.037128},{"month":11,"riseRate":0.75,"avgChangeRate":0.145001},{"month":12,"riseRate":0.5,"avgChangeRate":0.005825}],"exchange":"SEHK","name":"东阳光长江药业","nameEN":"HEC CJ PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光长江药业,01558,东阳光长江药业股票,东阳光长江药业股票老虎,东阳光长江药业股票老虎国际,东阳光长江药业行情,东阳光长江药业股票行情,东阳光长江药业股价,东阳光长江药业股市,东阳光长江药业股票价格,东阳光长江药业股票交易,东阳光长江药业股票购买,东阳光长江药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}